AXI

Search documents
大揭秘,OpenAI被扒了个底朝天!
华尔街见闻· 2025-06-20 10:44
(图片由豆包AI生成 提示词档案揭秘) 一个超过50页,逾万字的交互式报告,揭露了OpenAI从非营利研究实验室演变为营利巨头的全过程。 近期,由两大非营利科技监督组织——Midas Project与Tech Oversight Project——联合发布了一份名为《OpenAI档案》的深度调查报告。 该报告由Midas Project执行董事Tyler Johnston主导,历时近一年的公开信息收集与一个月的集中撰写。报告被称为"迄今为止,针对OpenAI在公司治理实 践、领导层诚信及组织文化方面,已记录在案的担忧的最全面汇编"。 通过梳理公司披露文件、法律诉讼、公开信及媒体报道等大量公开资料,这份超过一万字的交互式报告发现, OpenAI正在系统性地、有预谋完成了从"为人类 谋福祉"到"为投资者谋利润"的根本性转变,CEO奥特曼存在长期、有据可查的言行不一、操纵信息和规避监督的行为模式,且个人投资与公司业务的深度捆 绑。OpenAI在安全和透明度方面言行不一,其公开承诺与内部实践严重脱节。 报告分为四大主题,一是重组、二是首席执行官诚信、三是透明度和安全性、四是利益冲突。 其中,OpenAI高管和董事会成 ...
Tesla CEO Elon Musk has sold a compelling robotaxi vision. Execution is next.
Business Insider· 2025-06-20 10:36
Whatever one feels about Tesla's controversial CEO, Elon Musk, one thing is clear: the EV company and its leader know how to sell a robotaxi vision. As a testament: Tesla doesn't have a single robotaxi on the road providing paid rides, years after Musk has promised multiple times that it's just around the corner. The closest glimpse of an unmanned Tesla on public roads only came on June 10 with a short clip on X that showed a black Model Y appearing to drive itself on Austin's road with another Tesla trail ...
Biogen Initiates Phase 3 Pediatric Study of Omaveloxolone for the Treatment of Friedreich Ataxia
Globenewswire· 2025-06-18 11:30
Core Viewpoint - Biogen Inc. has initiated the BRAVE study, a global Phase 3 clinical trial to evaluate the efficacy and safety of omaveloxolone in children with Friedreich ataxia (FA) aged 2 to under 16 years, addressing a significant unmet need in the pediatric population [1][2][3]. Group 1: Study Design and Objectives - The BRAVE study will involve approximately 255 children with FA, randomized in a 2:1 ratio to receive either omaveloxolone or placebo for 52 weeks, followed by an open-label extension phase [2][4]. - The primary outcome measure is the change from baseline in the Upright Stability Score (USS), recognized as a sensitive measure of disease progression in children with FA [2][3]. - The study design has been informed by previous research and input from the FA community, with enrollment starting in the U.S. and plans to expand globally [4]. Group 2: Current Product Information - Omaveloxolone, marketed as SKYCLARYS, is currently approved for the treatment of FA in adults and adolescents aged 16 years and older in over 40 countries, including the U.S. and the European Union [1][5]. - The drug has received Orphan Drug, Fast Track, and Rare Pediatric Disease Designations from the U.S. FDA, highlighting its significance in treating this rare condition [5]. Group 3: Disease Context - Friedreich ataxia is a rare, genetic, life-shortening neuromuscular disorder, with early symptoms typically appearing in childhood and leading to significant disability [7][8]. - Patients with early onset FA often experience a more aggressive disease progression, underscoring the critical need for effective treatments in the pediatric population [3][7].
Tesla stock slips after report EV maker is halting Cybertruck and Model Y production
CNBC· 2025-06-17 16:34
A Tesla Cybertruck sits on a lot at a Tesla dealership on April 15, 2024 in Austin, Texas.Tesla shares slid more than 2% Tuesday after a report that the electric vehicle maker was halting production of Cybertruck and Model Y models for a week in Austin, Texas.The production stoppage begins June 30, Business Insider reported, citing a staff meeting where the announcement was made. The pause, which is for maintenance on production lines, would be the third such shutdown at the Austin facility in the past year ...
TSLA's Legacy or RIVN's Promise: Which EV Story Holds Up Better Now?
ZACKS· 2025-06-17 14:05
Key Takeaways Tesla's Q1 deliveries dropped 13% YoY, with margins sliding and U.S. EV share falling below 50%. Rivian trimmed 2025 delivery targets and burned cash, but aims for efficiency with its lower-cost R2 SUV. TSLA's energy unit shines bright, while RIVN posts gross margin gains for the second time in Q1.Tesla, Inc. (TSLA) and Rivian Automotive (RIVN) are two noted names in the electric vehicle (EV) space — one is an established giant, the other a young and ambitious startup.Tesla changed the game ...
X @Elon Musk
Elon Musk· 2025-06-16 04:30
RT Tesla Owners Silicon Valley (@teslaownersSV)Stepping into the Cybercab a fully autonomous robotaxi.https://t.co/DOYMoR3nYW ...
Robotaxi 近期跟踪
数说新能源· 2025-06-16 03:19
政策动态: 截止目前,上海、武汉、深圳、杭州等多地出台路权政策。上海后续将逐步释放更多的路权。各 主要城市已开放从有人测试到无人测试,再到示范应用和示范运营的路线,拿到无人化示范运营牌照后可商 业化收费。 主要玩家: 1)智驾技术主导型:如小马文远、百度等,以智驾技术为主导,逐步发展车队运营。其中小马 智行试驾表现和乘坐体验好,但单车成本最高;2)整车厂背景型:如曹操T3等,背后有整车厂背景。虽然规 模不大,但单车成本可压缩在二十几万到30万左右,具备一定商业化运营可能性;3)新入局者:京东、哈罗 等新入局者代表不同业态资本向该赛道渗透。 储能市场增长高于动力 成本构成: 考牌费用、车辆成本、人员成本、能源成本、其他成本。 商业化情况: 1)定价策略:以萝卜快跑武汉为例,采用高折策略,订单量高,乘客实付价格接近T3经济型 快车档甚至更低;2)盈利预期:萝卜快跑计划今年年底在武汉实现盈利,通过降低车辆成本、提高运营效率 等方式实现。例如百度RT6移动版单车成本20万出头,综合成本单日为150-200元,单日盈亏平衡点为20次 ASP20元的订单即可实现盈利。 商业模式: 1)整车厂模式。上汽、广汽、吉利等整车厂 ...
X @Tesla Owners Silicon Valley
Tesla Owners Silicon Valley· 2025-06-16 02:01
Stepping into the Cybercab a fully autonomous robotaxi.https://t.co/DOYMoR3nYW ...
Do You Want to Maximize Your Returns? Buy This Low-Risk, High-Yield Dividend Stock.
The Motley Fool· 2025-06-15 19:15
Core Viewpoint - Realty Income is positioned to maximize investor returns through a combination of high-yield dividends and solid growth prospects, making it an attractive investment option [2][14]. Dividend Performance - Realty Income has declared 660 consecutive monthly dividends and increased its dividend payment 131 times since its public listing in 1994, showcasing a strong commitment to returning capital to shareholders [4]. - The REIT has maintained a streak of 111 straight quarters and 30 consecutive years of dividend increases, with a compound annual growth rate of 4.2% in its payout during this period [4]. Financial Stability - Realty Income currently offers a dividend yield of 5.6%, supported by a stable income generated from a diversified portfolio of high-quality real estate, including retail, industrial, and gaming properties [5]. - The REIT conservatively pays out 75% of its adjusted funds from operations (FFO) in dividends, allowing it to retain excess cash flow for new investments [6]. Growth Consistency - Since its public market listing, Realty Income has delivered positive adjusted FFO per share growth every year except for 2009, demonstrating resilience through various economic conditions [8]. - The company has achieved a 5% compound annual FFO growth from 1996 to 2008 and 5.4% from 2009 to 2022, indicating its ability to grow even during periods of economic stress [9]. Market Potential - The total addressable market for net lease real estate in the U.S. and Europe is estimated at $14 billion, providing Realty Income with significant long-term growth potential [12]. - The REIT is expected to continue growing its adjusted FFO per share at a mid-single-digit annual rate over the long term [12]. Valuation Comparison - Realty Income trades at approximately 13 times its adjusted FFO, which is below the 18x average of other REITs in the S&P 500, indicating a compelling valuation [13]. - Despite trading at a discount to its peers, Realty Income has consistently delivered a higher operational return, averaging 9.7% over the past five years compared to 7.7% for its peers [13]. Total Return Potential - The combination of Realty Income's dividend yield, growth potential, and low valuation positions it well to deliver attractive total returns in the future, making it a strong investment choice for maximizing return potential [14].
X @Tesla Owners Silicon Valley
Tesla Owners Silicon Valley· 2025-06-14 15:22
🚨 BREAKING: The Trump administration is reportedly aiming to fast-track federal approvals for Tesla’s Cybercab, potentially clearing the way for a nationwide rollout of fully driverless robotaxis. https://t.co/KnOCO58UP1 ...